Phosphodiesterase 5 Inhibitor Is Effective Both CKD and Nephrotic Syndrome Models by Protecting Glomerular Filtration Barrier.
Proceedings for Annual Meeting of The Japanese Pharmacological Society
doi 10.1254/jpssuppl.93.0_1-ss-45
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Japanese Pharmacological Society